Key Highlights
- Citi launched IBM coverage with a Buy recommendation and $285 price objective
- Firm highlighted IBM’s defensive market position and artificial intelligence growth opportunities
- HashiCorp and Confluent deals expected to deliver significant cross-selling benefits
- Mainframe and Transaction Processing System refresh cycle positioned to boost revenues
- Shares declined approximately 1% Friday following the analyst initiation
On April 10, 2026, Citi launched its coverage of IBM with a Buy recommendation and established a $285 price objective. The bullish stance came from analyst Fatima Boolani and her team, who believe the market is undervaluing what IBM brings to the table.
International Business Machines Corporation, IBM
The investment firm’s analysis focuses heavily on IBM’s entrenched position within enterprise information technology infrastructure. Boolani’s group characterized the technology giant as “defensive in a tape increasingly hostile to enterprise software,” emphasizing its critical role in the world’s most important computing environments.
According to Citi’s assessment, IBM possesses “underappreciated scaffolding” essential for deploying and scaling production-grade artificial intelligence systems. This represents a substantially stronger position than simply being adjacent to AI trends — the analysts view IBM as fundamentally integrated into the AI infrastructure layer.
The financial institution also praised IBM’s recent acquisition strategy. Both the HashiCorp and Confluent transactions are anticipated to generate meaningful product integration and consulting opportunities throughout IBM’s existing business lines, leveraging the company’s extensive distribution network to maximize the return on these investments.
Artificial Intelligence Growth and Mainframe Revenue
Regarding top-line performance, Citi projects IBM can achieve high single-digit overall revenue expansion. This would represent meaningful acceleration from the company’s recent trajectory, with artificial intelligence demand identified as a critical growth catalyst.
IBM’s mainframe business cycle represents another important component of the investment thesis. The ongoing Transaction Processing System upgrade cycle should deliver dependable near-term revenue streams, while the company’s quantum computing initiatives offer longer-term optionality.
Citi’s analysts also emphasized IBM’s operational efficiency improvements. The recent merger and acquisition activity has positioned the company favorably on the cost side, which should support upward revisions to earnings per share projections and free cash flow generation moving forward.
Market Valuation and Internal Transactions
From a valuation perspective, IBM currently trades at 21.1x earnings — representing a discount relative to other large-cap and mega-cap software companies. Citi identified this valuation gap as a key element supporting an attractive risk/reward profile over the next twelve months.
IBM scores 83 out of 100 on the GF Score scale, with profitability metrics earning an 8/10 rating and growth scoring 7/10. The company’s financial strength registers at 5/10, representing an area that warrants monitoring.
Internal buying activity has shown positive trends. During the most recent three-month period, company insiders executed three purchase transactions totaling 1,484 shares, suggesting internal stakeholders have conviction in the company’s prospects.
Despite the favorable analyst coverage, IBM shares declined roughly 1% on Friday. The subdued market response isn’t particularly surprising, especially when new coverage launches coincide with broader market weakness.
IBM maintains a market capitalization of roughly $220.82 billion. The technology leader maintains operations spanning 175 countries and serves 95% of Fortune 500 organizations as customers.
Citi’s $285 price objective implies meaningful appreciation from present trading levels, and the coverage launch positions IBM as a compelling option for investors seeking defensive exposure within the technology sector.
